In the News 11/3/2020 • BioCentury Novartis vets Jimenez, Fishman thread digital into fabric of new VC firm Aditum, launch Tempero View
In the News 11/2/2020 • Reuters Japan’s Sosei allies with ex-Novartis team to develop neurological drug pipeline View
In the News 11/2/2020 • Fierce Biotech Novartis alums Jimenez, Fishman unveil their next act: Aditum Bio View
In the News 11/2/2020 • Endpoints News Joe Jimenez has one more thing to do in biopharma. And now he and Mark Fishman have a $133M stake to play the startup game View